Opendata, web and dolomites

ELIMINATE SIGNED

Development of strategies to eliminate cancer cells from the bone marrow

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ELIMINATE project word cloud

Explore the words cloud of the ELIMINATE project. It provides you a very rough idea of what is the project "ELIMINATE" about.

internationally    oncology    nature    mouse    persist    innovative    candidates    stroma    poses    largely    clinical    unexplored    informative    revolution    doubles    functional    organ    mortality    cohorts    shed    light    stage    fails    breaking    mechanisms    health    ongoing    microenvironment    grant    ground    activation    regulation    utmost    led    relates    generation    models    multidisciplinary    curable    eliminate    location    adaptive    originality    harness    hereby    cellular    survive    though    cancer    successful    expertise    malignant    eradicate    encompassing    anti    drug    strength    conduct    patient    cells    lymphatic    phenotypic    insights    despite    treatments    lies    question    immune    therapeutic    surprisingly    marrow    line    profiling    unresolved    bone    rate    sequencing    prime    aggressive    cure    innate    persisting    medical    unappreciated    suppressed    tumor    strategies    patients    bm    edge    hypothesis    technologies    cutting    molecular   

Project "ELIMINATE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF 

Organization address
address: Martinistrasse 52
city: HAMBURG
postcode: 20251
website: www.uke.uni-hamburg.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙490˙825 €
 EC max contribution 1˙490˙825 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF DE (HAMBURG) coordinator 1˙490˙825.00

Map

 Project objective

The bone marrow (BM) represents the prime location in which cancer cells survive aggressive treatments. This poses a major health challenge because the mortality rate of patients with curable cancer doubles if tumor cells persist in the BM. One unresolved question is why the immune system fails to eradicate cancer cells from this microenvironment even though it represents a lymphatic organ. Surprisingly, despite the ongoing revolution in immune oncology, the regulation and potential therapeutic activation of the immune response in the BM still remains largely unexplored. In this grant application a new line of research is proposed with the overall objective of understanding the cellular and molecular mechanisms, which control anti-cancer immune responses in the BM. The originality of this proposal relates to the hypothesis that innate and adaptive immune cells are suppressed by stroma cells in the BM. Therefore, we will conduct a comprehensive phenotypic and functional profiling of immune and stroma cells in the BM of cancer patients with and without persisting tumor cells. Based on these insights we will develop novel strategies to harness the immune system to eliminate malignant cells from the BM. The ground-breaking nature of the project is that it will shed light on the unappreciated immune microenvironment in the BM. Its specific strength lies in the multidisciplinary design encompassing informative patient cohorts, state-of-the-art mouse models and cutting-edge technologies including Next-Generation-Sequencing as well as innovative drug candidates. Hereby I can build on my internationally recognized expertise in the BM microenvironment field, which has already led to the successful development of a clinical-stage drug. Novel strategies to eliminate malignant cells from the bone marrow are of utmost medical importance because they would increase the cure rate of cancer patients.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ELIMINATE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ELIMINATE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  

EVOMENS (2020)

The evolution of menstruation in primates

Read More  

DISINTEGRATION (2019)

The Mass Politics of Disintegration

Read More